EP 0620739 A1 19941026 - METHOD OF TREATING TNF-DEPENDENT INFLAMMATION USING TUMOR NECROSIS FACTOR ANTAGONISTS.
Title (en)
METHOD OF TREATING TNF-DEPENDENT INFLAMMATION USING TUMOR NECROSIS FACTOR ANTAGONISTS.
Title (de)
VERFAHREN ZUR BEHANDLUNG TNF-ABHÄNGIGER ENTZÜNDUNGEN MITTELS TUMORNEKROSEFAKTOR-ANTAGONISTEN.
Title (fr)
PROCEDE DE TRAITEMENT DE L'INFLAMMATION DEPENDANTE DU FACTEUR NECROSANT DES TUMEURS MALIGNES (TNF) A L'AIDE D'ANTAGONISTES DUDIT TNF.
Publication
Application
Priority
- US 9308666 W 19930914
- US 94623692 A 19920915
Abstract (en)
[origin: WO9406476A1] A method for treating TNF-dependent inflammatory diseases in a mammal by administering a TNF antagonist, such as soluble TNFR.
Abstract (fr)
Procédé de traitement de maladies inflammatoires dépendantes du TNF chez un mammifère, consistant à administrer un antagoniste du TNF, tel qu'un récepteur de TNF soluble.
IPC 1-7
A61K 45/05; A61K 39/00; A61K 35/14; C07K 3/00; C07K 13/00; C07K 15/00; C12P 21/06; C12P 21/04; C12N 15/00; C12N 5/00
IPC 8 full level
C12N 15/09 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61P 29/00 (2006.01); C07K 14/52 (2006.01); C07K 14/525 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C07K 16/00 (2006.01); C07K 19/00 (2006.01); C12N 5/10 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01)
CPC (source: EP)
A61P 29/00 (2017.12); C07K 14/7151 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE CH DE ES FR GB IT LI LU NL SE
DOCDB simple family (publication)
WO 9406476 A1 19940331; AU 4920993 A 19940412; AU 670125 B2 19960704; CA 2123593 A1 19940331; CA 2123593 C 20000314; EP 0620739 A1 19941026; EP 0620739 A4 19970115; JP H07504203 A 19950511; KR 100232688 B1 19991201; NO 941780 D0 19940511; NO 941780 L 19940715; NZ 256293 A 19970624
DOCDB simple family (application)
US 9308666 W 19930914; AU 4920993 A 19930914; CA 2123593 A 19930914; EP 93921562 A 19930914; JP 50825294 A 19930914; KR 19940701636 A 19940514; NO 941780 A 19940511; NZ 25629393 A 19930914